Erythromycin B Oxime

N° de SZ CAT:	SZ-E006041
Número CAS	53274-43-4
Mol.F.	C37H68N2O12
Peso Molecular	733.0
Status de Fatura	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: (3R,4S,5S,6R,7R,9R,11S,12R,13R,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one

Sinônimo: 12-Deoxyerythromycin 9-Oxime

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: C[C@H]([C@H]([C@](O)(C[C@H](C([C@@H]1C)=NO)C)C)O[C@H](O[C@@H]2C)[C@@H]([C@H](C2)N(C)C)O)[C@@H]([C@H](C(O[C@@H]([C@@H]([C@@H]1O)C)CC)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC

Isolation and identification of a novel erythromycin-degrading fungus, Curvularia sp. RJJ-5, and its degradation pathway
By Ren, Jianjun; Deng, Liujie; Niu, Dongze; Wang, Zhenzhu; Fan, Bo; Taoli, Huhe; Li, Zhijie; Zhang, Jin; Li, Chunyu
From FEMS Microbiology Letters (2021), 368(1), fnaa215.

Development and validation of a stability indicating HPLC method for organic impurities of erythromycin stearate tablets
By Jeelani, Salika; Soukhova, Nadejda
From Journal of Pharmaceutical and Biomedical Analysis (2021), 195, 113858

Degradation and mineralization of erythromycin by heterogeneous photocatalysis using SnO2-doped TiO2 structured catalysts: Activity and stability
By Albornoz, L. L.; da Silva, S. W.; Bortolozzi, J. P.; Banus, E. D.; Brussino, P.; Ulla, M. A.; Bernardes, A. M.
From Chemosphere (2021), 268, 128858

Erythromycin B Oxime is chemically (3R,4S,5S,6R,7R,9R,11S,12R,13R,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one. It is also known as 12-Deoxyerythromycin 9-Oxime. Erythromycin B Oxime is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin B Oxime can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Erythromycin B Oxime

Contacts

Our Locations